Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited (APNHY) Revenue
Annual & quarterly revenue history · segment & region breakdown
APNHY · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAspen Pharmacare Holdings Limited trailing twelve-month (TTM) revenue is $83.20B, a decrease of 3.00% year-over-year from $43.36B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $43.36B | -$1.34B | -3.00% |
| 2024-06-30 | $44.71B | +$4.00B | +9.82% |
| 2023-06-30 | $40.71B | +$2.10B | +5.45% |
| 2022-06-30 | $38.61B | +$0.84B | +2.22% |
| 2021-06-30 | $37.77B | -$0.88B | -2.28% |
| 2020-06-30 | $38.65B | -$0.23B | -0.58% |
| 2019-06-30 | $38.87B | -$3.72B | -8.74% |
| 2018-06-30 | $42.60B | +$1.40B | +3.39% |
| 2017-06-30 | $41.20B | +$5.60B | +15.73% |
| 2016-06-30 | $35.60B | -$0.53B | -1.46% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare APNHY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Aspen Pharmacare Holdings Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Aspen Pharmacare Holdings Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in ZAR.
Data sourced from Aspen Pharmacare Holdings Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
APNHY revenue · 4 questionsAPNHY's trailing twelve-month (TTM) revenue is $83.20B. That is a decrease of 3.00% year-over-year from $43.36B in FY2025.
▸ Source: FMP · Aspen Pharmacare Holdings Limited SEC filings · GAAP · Aspen Pharmacare Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026